Brain-Scan AI could spot Parkinson's without costly PET imaging
NCT ID NCT04334902
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed trial tested a software called mPDia that uses MRI brain scans to help doctors diagnose neurodegenerative parkinsonism, a group of movement disorders including Parkinson's disease. The study involved 221 adults and compared mPDia's accuracy to standard PET scans. The goal was to see if this AI tool could provide a simpler, more widely available diagnostic option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- mPDia clinical decision support software (device)
- What this could lead to
- If successful, mPDia could offer a faster, more accessible way to diagnose parkinsonism using standard MRI instead of expensive PET scans.
- What could go wrong
- This is a retrospective study, not a prospective trial, so real-world performance may differ. The software's accuracy depends on MRI quality and may not replace PET scans in all cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIAGNOSES DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asan Medical Center
Seoul, South Korea
-
Catholic University of Korea, Seoul ST. Mary's Hospital
Seoul, South Korea
-
Cha Medical Center
Gyeonggi-do, South Korea
-
Gachon University Gil Medical Center
Incheon, South Korea
-
Gangnam Severance Hospital
Seoul, South Korea
-
Hallym University Dongtan Sacred Heart Hospital
Gyeonggi-do, South Korea
-
Hallym University Sacred Heart Hospital
Gyeonggi-do, South Korea
-
Korea University Ansan Hospital
Gyeonggi-do, South Korea
-
Korea University Guro Hospital
Seoul, South Korea
-
KyungHee University Medical Center
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Marathon runners and heart patients put a new troponin test to the ultimate challenge
- New study aims to catch lung cancer early in french smokers
- AI boosts cataract surgery precision for severely nearsighted patients
- Does your income affect your cancer care? new study investigates
- Could a simple stool test revolutionize TB diagnosis for kids and HIV patients?
- New diagnostic strategy aims to end diagnostic odyssey for rare diseases